Kezar Life Sciences KZR
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 6.29 | 104.25 | -1.99 | -15,164 | -15 | |
| 2025Q3 | 3.90 | 98.64 | -1.53 | -11,715 | -11 | |
| 2025Q2 | 4.58 | 108.93 | -1.87 | -14,599 | -14 | |
| 2025Q1 | 4.88 | 108.76 | -2.27 | -17,629 | -17 | |
| 2024Q4 | 6.72 | 115.77 | -2.77 | -21,563 | -20 | |
| 2024Q3 | 7.73 | 110.24 | -2.79 | -21,948 | -20 | |
| 2024Q2 | 6.00 | 110.58 | -2.92 | -23,383 | -22 | |
| 2024Q1 | 9.02 | 111.54 | -2.98 | -23,711 | -22 | |
| 2023Q4 | 9.47 | 108.56 | -4.44 | -34,589 | -32 | |
| 2023Q3 | 11.90 | 112.42 | -3.20 | -25,527 | -23 | |
| 2023Q2 | 24.50 | 111.96 | -3.30 | -26,784 | -24 | |
| 2023Q1 | 31.30 | 112.35 | -3.10 | -24,524 | -22 | |
| 2022Q4 | 70.40 | 112.35 | -2.53 | -20,034 | -18 | |
| 2022Q3 | 86.10 | 107.93 | -2.40 | -18,927 | -18 | |
| 2022Q2 | 82.70 | 102.56 | -2.60 | -16,323 | -16 | |
| 2022Q1 | 166.20 | 100.68 | -2.60 | -15,878 | -16 | |
| 2021Q4 | 167.20 | 100.36 | -2.60 | -14,103 | -14 | |
| 2021Q3 | 86.40 | 100.26 | -2.80 | -14,499 | -14 | |
| 2021Q2 | 54.30 | 100.36 | -2.50 | -13,009 | -13 | |
| 2021Q1 | 59.60 | 100.42 | -2.50 | -13,048 | -13 |